RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,561,959 | +288.7% | 515,160 | +337.3% | 0.00% | +300.0% |
Q2 2023 | $2,202,710 | +134129.7% | 117,792 | +31.7% | 0.00% | 0.0% |
Q1 2023 | $1,641 | +51.8% | 89,416 | +63.7% | 0.00% | 0.0% |
Q4 2022 | $1,081 | -100.0% | 54,606 | -64.6% | 0.00% | -50.0% |
Q3 2022 | $3,713,000 | +12.6% | 154,324 | -14.6% | 0.00% | 0.0% |
Q2 2022 | $3,298,000 | +91.0% | 180,691 | +130.1% | 0.00% | +100.0% |
Q1 2022 | $1,727,000 | +58.9% | 78,521 | +165.3% | 0.00% | 0.0% |
Q4 2021 | $1,087,000 | -94.2% | 29,598 | -95.1% | 0.00% | -90.9% |
Q3 2021 | $18,735,000 | +72.3% | 603,407 | +76.4% | 0.01% | +57.1% |
Q2 2021 | $10,871,000 | +11.8% | 341,972 | -21.9% | 0.01% | 0.0% |
Q1 2021 | $9,725,000 | +38.0% | 438,055 | +22.8% | 0.01% | +40.0% |
Q4 2020 | $7,045,000 | +6.7% | 356,663 | +73.9% | 0.01% | -37.5% |
Q3 2020 | $6,605,000 | +538.2% | 205,145 | +475.4% | 0.01% | +700.0% |
Q2 2020 | $1,035,000 | +9.8% | 35,652 | -19.6% | 0.00% | -50.0% |
Q1 2020 | $943,000 | – | 44,317 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |